ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Hialeah, Florida. The medical center, Concentra Hialeah, is conveniently located at 855 East 8th Avenue, Hialeah, Florida 33010. "Hialeah has shown great potential for Concentra,†said Janet Cobb, MD, senior vice president of Concentra medical operations. "By optimizing our presence in Hialeah, we intend to serve more employers and provide. ...

Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Concentra Group Holdings Parent, Inc. (NYSE:CON) has a “Buy” or equivalent rating from all seven analysts covering the stock. While the target price ranges from $25 to $31, the median price target of $29 implies an upside potential of 48.95% from the current price. After Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its third-quarter results on November 6, several ...

Economic Policy and Budget - UK Chancellor Rachel Reeves is set to present the Autumn Budget on November 26, 2025, focusing on economic growth and fiscal stability, emphasizing that "growth is the best way out of the challenges that we face" [2][8] - The budget includes a commitment to a £86 billion R&D budget over four years starting April 2026, which features a £500 million Local Innovation Partnerships Fund, although this represents a real-terms freeze based on inflation forecasts [3][8] - Economists predict tax increases and spending adjustments totaling around £30 billion to meet fiscal rules, with employer National Insurance contributions expected to rise to 15% from April 2026 [4][8] Corporate Developments - Alphabet (GOOGL) shares surged by 4.1% in premarket trading on November 24, 2025, driven by optimism surrounding Google's AI initiatives and a new multi-million-dollar cloud partnership with NATO [5][6][8] - Continental (CON) plans to cut up to 1,500 jobs in its ContiTech division starting in 2026, aiming for annual savings of €150 million (approximately $173.16 million) by 2028 due to underperforming markets [7][9][8] - Tesla (TSLA) shares rose by 2.2% in premarket trading on November 24, 2025, attributed to positive market sentiment and expectations of potential Federal Reserve interest rate cuts, with a reported revenue increase of 12% year-over-year in Q3 [12][13][8] Market Sentiment and Economic Indicators - German business sentiment declined in November 2025, with the Ifo Business Climate Index falling to 88.1 from 88.4 in October, indicating a pessimistic outlook for the economy [10][11] - The manufacturing sector in Germany faces challenges, with companies reporting low order books and increased skepticism about future conditions, influenced by high energy costs and intensified competition [11]

Core Insights - Concentra has appointed Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer to enhance its data strategy and governance, aligning with enterprise growth priorities [1][2] Company Overview - Concentra is the largest provider of occupational health services in the United States, operating 628 occupational health centers and 413 onsite health clinics across 47 states, serving over 50,000 patients daily as of September 30, 2025 [4] Leadership and Expertise - Jason Cooper brings over 25 years of experience in data and technology across various sectors, including roles at L3-Communications, CVS Caremark, and Cigna, which will aid in operationalizing data and accelerating AI adoption at Concentra [2][3] Strategic Focus - The company emphasizes a data-driven approach, focusing on data governance and digital connectivity to enhance its position as an industry leader [3]

Financial Data and Key Metrics Changes - Total company revenue was $572.8 million in Q3 2025, representing a 17% year-over-year growth compared to $489.6 million in Q3 2024 [3] - Adjusted EBITDA was $118.9 million in Q3 2025, a 17.1% increase from $101.6 million in the same quarter prior year [7] - Adjusted net income attributable to the company was $49.9 million, with adjusted earnings per share of $0.39, compared to $44.3 million and $0.37 in the prior year [8] Business Line Data and Key Metrics Changes - In the Occupational Health operating segment, total revenue was $526 million in Q3 2025, a 13.6% increase from the prior year [9] - Workers' compensation revenue was $343.5 million, up 15% year-over-year, with visits per day increasing 9.8% [9] - Employer services revenue increased by 11.9% to $173.2 million, with visits per day up 8.9% [9] Market Data and Key Metrics Changes - Total patient visits increased 9.2% in the quarter to more than 55,500 visits per day [3] - Workers' compensation visits per day increased 9.8%, while employer services visit volumes increased 8.9% relative to the prior year [4] - The company noted a strong correlation between workers' compensation volume and employment levels reported by the BLS, although recent data showed a lack of correlation [5] Company Strategy and Development Direction - The company finalized the integration and rebranding of the Nova Occupational Health Centers and opened additional centers, with plans for more by year-end [2] - The focus is on organic growth and capturing market share, particularly in the on-site health clinics segment, which reported a 123.8% revenue increase due to the acquisition of Pivot OnSite Innovations [11] - The company is shifting back to its core acquisition strategy after integrating Nova and Pivot, targeting smaller practices with one to five occupational health centers [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, indicating no significant headwinds or obstacles anticipated for 2026 [33] - The company is focused on leveraging technology to improve customer engagement and operational efficiencies, which is seen as a competitive advantage [49][50] - Management expects a strong rate year in California and anticipates similar rate increases for employer services in line with inflation [66] Other Important Information - The company ended the quarter with a total debt balance of $1.61 billion and a cash balance of $50 million, with a net leverage ratio of 3.6x [17] - A cash dividend of $0.0625 per share was declared, payable on December 9, 2025 [21] - The company raised the low end of its 2025 revenue guidance from $2.13 billion to $2.145 billion [22] Q&A Session Summary Question: Any major headwinds or tailwinds for 2026? - Management sees no significant headwinds and remains bullish about the upcoming year [33] Question: What is driving the improvement in employer services volume? - The company has implemented various sales and marketing strategies, leveraging technology to enhance customer engagement and retention [37] Question: Can you elaborate on the decoupling of workers' comp visit volume from BLS data? - Management noted a lack of correlation over the past two years, which was previously strong, and is uncertain about the factors driving this change [46] Question: How stable is the labor force and cost environment? - The company reported stability in labor force statistics and turnover rates, with no significant changes in costs [54] Question: What are the rate expectations for 2026? - Management expects a strong rate year for workers' comp, particularly in California, and normal rate increases for employer services in line with inflation [66]

Q3 2025 Performance - Total revenue increased by 170% year-over-year, reaching $5728 million, with a 106% increase excluding the impact of the Nova acquisition[12] - Adjusted EBITDA grew by 171% year-over-year to $1189 million, with a slight increase in Adjusted EBITDA margin to 208%[11, 12] - Workers' Compensation visits per day (VPD) increased by 44% year-over-year, excluding the impact of the Nova acquisition[11] - Employer Services VPD increased by 19% year-over-year[11] - Revenue per visit (RPV) increased by 42% year-over-year to $147[11] YTD 2025 Performance - Total revenue increased by 132% year-over-year, reaching $16243 billion[13] - Adjusted EBITDA increased by 125% year-over-year to $3366 million[13] - Capital expenditures increased by 305% year-over-year to $622 million, including approximately $11 million of one-time transition capex for Nova[13] Financial Position and Guidance - The company is focused on deleveraging, with net leverage lowered to 36x in Q3 2025 and on pace for ≤35x by year-end[11] - The revolving credit facility was completely paid down, with $50 million repaid in Q3 and $35 million repaid in October[11] - Full-year 2025 guidance for revenue was raised to $2145 billion - $2160 billion, and Adjusted EBITDA guidance was raised to $425 million - $430 million[11, 18]

分组1 - Concentra Group reported quarterly earnings of $0.39 per share, exceeding the Zacks Consensus Estimate of $0.37 per share, and showing an increase from $0.37 per share a year ago, resulting in an earnings surprise of +5.41% [1] - The company achieved revenues of $572.8 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.31%, and up from $489.64 million year-over-year [2] - Concentra has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has underperformed the market, losing about 3.2% since the beginning of the year, while the S&P 500 gained 15.6% [3] - The current consensus EPS estimate for the upcoming quarter is $0.25 on revenues of $532.44 million, and for the current fiscal year, it is $1.32 on revenues of $2.15 billion [7] - The Medical Services industry, to which Concentra belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Company Operations - As of September 30, 2025, the company operated 628 standalone occupational health centers and 413 onsite health clinics across 47 states and the District of Columbia[130]. - The company’s onsite health clinics serve medium to large-sized employers, providing a range of occupational health services[135]. - The company’s telemedicine program serves 43 states and the District of Columbia, enhancing its service delivery capabilities[130]. - The company’s operating segments are aggregated into a single reportable segment based on similar services and economic characteristics[133]. Revenue and Growth - For the three months ended September 30, 2025, revenue from occupational health centers accounted for 92% of total revenue, while onsite health clinics contributed 6%[133]. - Revenue increased 17.0% to $572.8 million for the three months ended September 30, 2025, compared to $489.6 million for the same period in 2024, driven by an increase in patient visits and revenue per visit[156]. - Revenue increased by 13.2% to $1,624.3 million for the nine months ended September 30, 2025, compared to $1,435.2 million for the same period in 2024, driven by increased patient visits and revenue per visit[167]. Patient Visits and Revenue per Visit - Total patient visits rose 9.2% to 3,557,697 for the three months ended September 30, 2025, compared to 3,258,605 visits in the same period of 2024[157]. - Revenue per visit increased 4.2% to $147.31 for the three months ended September 30, 2025, compared to $141.42 for the same period in 2024[158]. - Total patient visits rose by 6.8% to 10,282,385 for the nine months ended September 30, 2025, compared to 9,628,515 visits for the same period in 2024[168]. - Revenue per visit increased by 4.7% to $146.72 for the nine months ended September 30, 2025, compared to $140.12 for the same period in 2024[169]. Acquisitions - The company acquired Nova Medical Centers for $265 million, financed through $102.1 million in new debt and $50 million from existing credit facilities[137]. - The acquisition of Pivot Onsite Innovations for $54.4 million expanded the company's onsite health clinics to over 400 locations[140]. - The company added over 240 onsite locations through acquisition in June 2025, contributing to revenue growth[156]. - The company completed the acquisition of Nova for $102.1 million and Pivot Onsite Innovations for $35.0 million, financed through a combination of debt and cash on hand[195]. Financial Performance - Net income attributable to the Company was $48.3 million for the three months ended September 30, 2025, compared to $44.3 million for the same period in 2024[151]. - Adjusted EBITDA for the three months ended September 30, 2025, was $118.9 million, or 20.8% of revenue, compared to $101.6 million, or 20.7% of revenue, in the same period of 2024[151]. - For the nine months ended September 30, 2025, adjusted net income attributable to the company was $139.8 million, or $1.09 per share, compared to $146.2 million, or $1.33 per share for the same period in 2024, indicating a decrease of 4.8% in adjusted net income[187]. Expenses - Cost of services was $405.5 million, or 70.8% of revenue, for the three months ended September 30, 2025, down from 71.7% in the same period of 2024[160]. - General and administrative expenses increased to $52.9 million, or 9.2% of revenue, for the three months ended September 30, 2025, compared to 7.6% in the same period of 2024[161]. - Interest expense for the three months ended September 30, 2025, was $28.7 million, up from $21.4 million in the same period of 2024, due to increased borrowings[164]. - Cost of services was $1,152.0 million, or 70.9% of revenue, for the nine months ended September 30, 2025, down from 71.6% of revenue in the same period in 2024[170]. - General and administrative expenses increased to $152.5 million, or 9.4% of revenue, for the nine months ended September 30, 2025, compared to 7.7% of revenue in the same period in 2024[171]. - Interest expense rose significantly to $82.4 million for the nine months ended September 30, 2025, compared to $21.3 million for the same period in 2024, due to new debt issuances[175]. Cash Flow and Capital Structure - Cash flows from operating activities for the nine months ended September 30, 2025, were $160.7 million, down from $181.0 million in 2024, primarily due to increased interest payments following debt recapitalization[191]. - Investing activities used $394.7 million in cash for the nine months ended September 30, 2025, compared to $54.6 million in 2024, with $333.3 million allocated for acquisitions, including Nova and Pivot Onsite Innovations[192]. - The company had $393.0 million of availability under its Revolving Credit Facility as of September 30, 2025, after accounting for $35.0 million of borrowings and $22.0 million of outstanding letters of credit[200]. - The company had a net working capital of $62.8 million at September 30, 2025, down from $130.0 million at December 31, 2024, primarily due to cash depletion from acquisitions[195]. Shareholder Returns - The company declared a cash dividend of $0.0625 per share on November 5, 2025, with a total of $24.0 million paid in dividends throughout 2025[208]. - The company authorized a share repurchase program to buy back up to $100 million of its outstanding common stock, set to expire on December 31, 2027[207]. Debt and Interest Rate Management - The company entered into derivative contracts to mitigate exposure to variable Term SOFR interest rates, limiting the rate to a fixed 3.829% on $300.0 million of principal outstanding[202]. - As of September 30, 2025, the company had outstanding borrowings of $945.3 million in term loans and $35.0 million in the Revolving Credit Facility, both subject to variable interest rates[215]. - The company entered into a derivative swap contract effective March 3, 2025, limiting the Term SOFR rate to a fixed rate of 3.829% on $300 million of principal outstanding under its term loan, applicable through February 29, 2028[216]. - A derivative collar contract was also established, capping the Term SOFR rate at 4.500% and setting a floor at 3.001% on $300 million of principal outstanding under the term loan, effective March 3, 2025[217]. - A 0.25% increase in market interest rates will increase the annual interest expense on the company's variable rate debt by $1.0 million, with an additional impact of $0.8 million due to the Term SOFR rate cap[218].

Financial Performance - Revenue for Q3 2025 increased by 17.0% to $572.8 million, compared to $489.6 million in Q3 2024[4] - Net income for Q3 2025 was $49.8 million, an increase of 8.9% from $45.8 million in Q3 2024[5] - Adjusted EBITDA rose by 17.1% to $118.9 million in Q3 2025, up from $101.6 million in Q3 2024[5] - Revenue for the nine months ended September 30, 2025, was $1,624,337, representing a 13.2% increase from $1,435,151 in 2024[25] - Net income for the nine months ended September 30, 2025, was $136,658, a decrease of 8.8% from $149,097 in 2024[34] - Basic and diluted earnings per share for the nine months ended September 30, 2025, was $1.03, compared to $1.32 in 2024[28] - Net income for Q3 2025 was $49,822, representing 8.7% of revenue, compared to $45,759 (9.3%) in Q3 2024[44] - Adjusted net income attributable to the company for Q3 2025 was $49,929, or $0.39 per share, compared to $44,306 ($0.37) in Q3 2024[49] Operational Metrics - Patient visits totaled 3,557,697 in Q3 2025, averaging 55,589 visits per day, a 9.2% increase from Q3 2024[5] - Total patient visits for the nine months ended September 30, 2025, were 10,282,385, a 6.8% increase compared to 9,628,515 in 2024[38] - The number of occupational health centers increased to 628 by the end of September 2025, up from 549 in 2024, with 72 centers acquired during the period[38] - The company operated 413 onsite health clinics by the end of September 2025, compared to 156 in 2024[38] - Revenue per visit for workers' compensation increased by 4.7% to $211.82 in Q3 2025 from $202.29 in Q3 2024[36] Financial Position - The company reported a cash balance of $49.9 million and reduced net leverage to 3.6x as of September 30, 2025[8] - Total assets increased to $2,843,930 as of September 30, 2025, from $2,521,164 at the end of 2024[32] - Cash at the end of the period decreased to $49,941 from $183,255 at the beginning of the period[32] - Current liabilities increased slightly to $312,650 as of September 30, 2025, compared to $307,186 at the end of 2024[32] Expenses and Costs - Total costs and expenses rose by 14.3% to $1,360,024 for the nine months ended September 30, 2025, from $1,189,759 in 2024[25] - Interest expense surged by 287.4% to $82,424 in 2025, compared to $21,275 in 2024[25] - Interest expense for Q3 2025 was $28,683, which is 5.0% of revenue, compared to $21,369 (4.4%) in Q3 2024[44] - Cash paid for interest increased significantly to $94,135 in 2025 from $34,221 in 2024[34] Guidance and Future Expectations - Concentra raised its full-year 2025 revenue guidance to a range of $2.145 billion to $2.160 billion[17] - The company expects full-year 2025 adjusted EBITDA to be in the range of $425 million to $430 million[54] - The anticipated net income attributable to the company for 2025 is projected between $156 million and $161 million[54] Shareholder Actions - A cash dividend of $0.0625 per share was declared, payable on December 9, 2025[10] - The company authorized a share repurchase program of up to $100 million, set to expire on December 31, 2027[12] Capital Expenditures - Capital expenditures for 2025 are expected to be in the range of $80 million to $90 million[17] Other Financial Activities - The company reported a loss on early retirement of debt amounting to $875 in 2025, with no such loss reported in 2024[25] - The company reported a net cash used in investing activities of $394,725 for the nine months ended September 30, 2025, compared to $54,579 in 2024[34] - Separation transaction costs for Q3 2025 were $1,025, representing 0.2% of revenue[44] - The company incurred $1,181 in acquisition costs related to Nova and Pivot Onsite Innovations in Q3 2025[44]

Financial Performance - Consolidated Edison reported a net income of $688 million or $1.91 per share for Q3 2025, an increase from $588 million or $1.70 per share in Q3 2024, representing a 17% increase in net income [1][11] - For the first nine months of 2025, net income was $1,726 million or $4.84 per share, compared to $1,510 million or $4.37 per share in the same period of 2024, marking a 14% increase [2][11] - Adjusted earnings for Q3 2025 were $686 million or $1.90 per share, up from $583 million or $1.68 per share in Q3 2024 [1][11] Strategic Initiatives - The company has reached a Joint Settlement Agreement on a three-year investment plan aimed at funding critical infrastructure investments while maintaining affordability and reliability [3] - Con Edison plans to complete the construction of 14 new substations and implement upgrades and storm resiliency measures by 2030 to support growing energy demands [3] Future Outlook - The company expects adjusted earnings per share for 2025 to be in the range of $5.60 to $5.70, slightly up from the previous forecast of $5.50 to $5.70 [3] - Adjusted earnings per share exclude specific impacts such as the basis difference of Con Edison's equity investment in Mountain Valley Pipeline and other strategic evaluations [3][8]